Novel Thrombectomy Device Provides Effective Treatment for Patients With Peripheral Arterial Disease

    PARK CITY, UT, August 02, 2016 /24-7PressRelease/ -- Dr. Trent Prault, Vascular Surgeon with Harbin Clinic Vascular Surgery in Rome, Georgia, was successful in using a novel thrombectomy device to remove emboli from a patient's leg.

The patient presented with claudication post femoral artery endarterectomy (surgical removal of plaque). Dr. Prault performed an atherectomy of a restenosis at the origin of the superficial femoral artery. Often times, multiple technologies are needed to treat this disease. After atherectomy (a procedure utilizing a device that removes calcium in the vessels), a blockage was noted in the mid SFA. Dr. Prault used the Aspire Mechanical Thrombectomy System to remove the remaining blockage. He then placed a stent and a final angiogram revealed a patent superficial femoral artery and blood flow to the foot.

"Office based procedures provide benefits to my patients. We make sure safety and positive outcomes are the priority," said Dr. Prault. "The ASPIRE Mechanical Thrombectomy System provides me a tool to take care of my patients. I need a simple and cost effective way to treat these patients. In today's healthcare environment this is exactly what I need."

The ASPIRE Mechanical Thrombectomy System allows clinicians to instantly start, stop, increase, decrease, pulse, or maintain thrombectomy force during a procedure. ASPIRE Mechanical Aspirators also aspirate up to 280ml, almost 10 times more than basic syringe-based systems, without multiple messy and time-consuming catheter connections, disconnections, and re-connections to improve speed and performance.

"Clinically effective devices that are simple to use and cost less than other devices improve our healthcare system," said Chris Livingstone, VP of Sales and Marketing for Control Medical Technology. "The Aspire Mechanical Thrombectomy System is simple to set up, requires no capital equipment and provides economic value to hospitals and physician's offices. We believe our device is a tool that can provide physicians improved speed, force, volume and control while also lowering their cost. This is a win/win combination for all."

The patented ASPIRE Mechanical Thrombectomy System is available by itself or in kits that include an over-the-wire or rapid exchange thrombectomy catheter. ASPIRE Mechanical Aspirators may also be connected to any thrombectomy catheter the clinician chooses.

Control Medical Technology designs, develops, and markets innovative thrombus management, biopsy, and aspiration devices, including the patented ASPIRE Mechanical Aspirator, ASPIRE RX-LP6 Mechanical Thrombectomy System, and ASPIRE MAX Thrombectomy System. For more information, call 1-954-457-9345 or visit www.CONTROLMEDTECH.com.

# # #